SOMAXON PHARMACEUTICALS, INC.

• Medical Stocks That Can Make You Sleep

  By Josef Ray Dagatan - December 15, 2012 | Tickers: PTX, SOMX.DX, TSPT

  Silenor, a drug used to treat those who have trouble sleeping, is the focus in the commercial activities of Somaxon Pharmaceuticals (UNKNOWN: SOMX.DX). It has earned the specialty pharmaceutical company a gain in the stock market of 80% to $2.94 in the Dec 13 close. The medicine is approved by the FDA for the treatment of insomnia and is considered non-addictive. Results of clinical trials show that it maintains more »

• Biopharma stocks: 3 Small-caps that have bottomed out in November

  By Jorge Aura - December 6, 2012 | Tickers: DVAX, HZNP, SOMX.DX

  All investors know the risks of biotechnology companies. The strong volatility of these companies makes their prices fluctuate in excess. This sector has the peculiarity that offers a high risk but with a possible high gain. Identify pharmaceutical companies that have bottomed out or that are undervalued can be a good investment strategy for medium-term and short-term.

  In the following table will be able to see the readers, 3 companies more »